Ofir focuses his practice on representing underwriters and issuers, predominantly in the technology and life sciences industries, in a range of capital markets transactions, including initial public offerings, follow-on equity offerings, at-the-market offerings and other public and private equity offerings. Ofir has experience working with emerging companies on a variety of complex corporate and financing matters from inception to exit, and he regularly counsels clients on general corporate and securities law matters, including day-to-day corporate governance, SEC reporting and stock exchange rules and requirements.

Download full bio